CN117925747A - Application of Serratia marcescens in co-production of prodigiosin and diltiazem intermediate - Google Patents
Application of Serratia marcescens in co-production of prodigiosin and diltiazem intermediate Download PDFInfo
- Publication number
- CN117925747A CN117925747A CN202311835867.4A CN202311835867A CN117925747A CN 117925747 A CN117925747 A CN 117925747A CN 202311835867 A CN202311835867 A CN 202311835867A CN 117925747 A CN117925747 A CN 117925747A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- prodigiosin
- diltiazem
- mpgm
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HCOLPNRPCMFHOH-UHFFFAOYSA-N Prodigiosin Natural products CCCCCC1C=C(C=C/2N=C(C=C2OC)c3ccc[nH]3)N=C1C HCOLPNRPCMFHOH-UHFFFAOYSA-N 0.000 title claims abstract description 107
- TWFGRJUTAULJPZ-USZBIXTISA-N prodigiosin Chemical compound N1=C(C)C(CCCCC)=C\C1=C/C1=NC(C=2[N]C=CC=2)=C[C]1OC TWFGRJUTAULJPZ-USZBIXTISA-N 0.000 title claims abstract description 107
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 title claims abstract description 94
- 229960004166 diltiazem Drugs 0.000 title claims abstract description 94
- 241000607715 Serratia marcescens Species 0.000 title claims abstract description 56
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 42
- 238000000855 fermentation Methods 0.000 claims abstract description 138
- 230000004151 fermentation Effects 0.000 claims abstract description 138
- 235000013379 molasses Nutrition 0.000 claims abstract description 22
- 239000012137 tryptone Substances 0.000 claims abstract description 22
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 48
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 40
- 239000007788 liquid Substances 0.000 claims description 34
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 20
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 20
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 19
- 229920000053 polysorbate 80 Polymers 0.000 claims description 19
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000004321 preservation Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 238000010564 aerobic fermentation Methods 0.000 claims 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- 238000005273 aeration Methods 0.000 claims 1
- 238000012807 shake-flask culturing Methods 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 239000000543 intermediate Substances 0.000 abstract description 89
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 26
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 13
- 229910052799 carbon Inorganic materials 0.000 abstract description 13
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 13
- 238000000034 method Methods 0.000 abstract description 11
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 40
- 239000001963 growth medium Substances 0.000 description 33
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 230000000694 effects Effects 0.000 description 22
- 239000000243 solution Substances 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 17
- 239000002054 inoculum Substances 0.000 description 17
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 14
- 235000010633 broth Nutrition 0.000 description 14
- 238000011068 loading method Methods 0.000 description 10
- 238000012258 culturing Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 239000000306 component Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000012264 purified product Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 108090001060 Lipase Proteins 0.000 description 5
- 239000004367 Lipase Substances 0.000 description 5
- 102000004882 Lipase Human genes 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000002329 infrared spectrum Methods 0.000 description 5
- 235000019421 lipase Nutrition 0.000 description 5
- 241000894007 species Species 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000009630 liquid culture Methods 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000009423 ventilation Methods 0.000 description 3
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 240000000111 Saccharum officinarum Species 0.000 description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000011914 asymmetric synthesis Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- 108010029692 Bisphosphoglycerate mutase Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- -1 p-methoxyphenyl glycidyl Chemical group 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000020422 sugar cane juice Nutrition 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- CMQCNTNASCDNGR-UHFFFAOYSA-N toluene;hydrate Chemical compound O.CC1=CC=CC=C1 CMQCNTNASCDNGR-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/425—Serratia
- C12R2001/43—Serratia marcescens
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses an application of Serratia marcescens in co-production of prodigiosin and diltiazem intermediates, and belongs to the technical field of bioengineering. According to the invention, molasses is used as a carbon source, tryptone is used as a nitrogen source, prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM are fermented and synthesized, the yield of prodigiosin obtained by fermentation is up to 27.6g/L, and the yield of diltiazem intermediate (2R, 3S) - (-) -MPGM is 17.3g/L. The operation method disclosed by the invention is simple, has a short production period, has a great industrial popularization and application prospect, and simultaneously provides a novel process for biosynthesis of prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM.
Description
Technical Field
The invention belongs to the technical field of bioengineering, and particularly relates to application of Serratia marcescens in co-production of prodigiosin and diltiazem intermediates.
Background
Prodigiosin (Prodigiosins, PG) is a natural red pigment produced by microorganisms and is a secondary metabolite. There is a great deal of attention for their anti-inflammatory, antibacterial, antioxidant, various biological activities, antitumor effects, etc. The main production method of the prodigiosin is a microbial fermentation method at present, and the prodigiosin yield is improved by optimizing the components of fermentation liquor, the culture conditions, the culture environment and the culture time because the prodigiosin yield is closely related to the composition of a culture medium and the culture conditions.
Diltiazem is a cardiovascular and cerebrovascular medicine commonly used in clinic, has good efficacy and wide clinical applicability, and has considerable market prospect at home and abroad. Diltiazem is generally synthesized by chemical resolution, asymmetric synthesis and biological resolution. However, the asymmetric synthesis reaction conditions are harsh, the resolution reagent is expensive, the cost is high, and the requirements of industrial production are not met, so that the diltiazem is synthesized by a resolution method which is easy to operate and environment-friendly. The method is suitable for large-scale industrial production, high in efficiency, low in toxicity, low in cost and simple in operation, and general attention in the pharmaceutical field is paid. And the lipase produced by Serratia marcescens can be used for resolution of trans-4-p-methoxyphenyl glycidyl acid methyl ester [ (+ -) -MPGM ] on the synthetic route to obtain p-methoxyphenyl glycidyl acid methyl ester [ (2R, 3S) - (-) -MPGM ], which is a key intermediate for synthesizing diltiazem. The (+/-) -MPGM is directly split by using Serratia marcescens fermentation broth, and high-yield prodigiosin and diltiazem key intermediate (2R, 3S) - (-) -MPGM can be obtained, so that the production period is shortened, and the production cost is reduced.
Through searching, no related report of the coproduction of the prodigiosin and the diltiazem intermediate by Serratia marcescens is currently found.
Disclosure of Invention
The invention aims to: the invention aims to solve the problem of providing a method for co-producing prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM by utilizing serratia marcescens, preparing prodigiosin by utilizing serratia marcescens fermentation, and simultaneously resolving trans-4-p-methoxyphenyl glycidic acid methyl ester [ (+ -) -MPGM ] by utilizing lipase of lipase in serratia marcescens fermentation liquid to obtain p-methoxyphenyl glycidic acid methyl ester [ (2R, 3S) - (-) -MPGM ], thereby improving production efficiency and reducing production cost.
The technical scheme is as follows: in order to solve the problems, the invention adopts the following technical scheme:
Serratia marcescens is applied to coproduction of prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM.
The Serratia marcescens is named as Serratia marcescens LT-7 (SERRATIA MARCESCENS LT-7) which is preserved in China center for type culture Collection (CCTCC for short), and the preservation address is: eight ways in the mountain area of the city of Wuhan in Hubei province, wuhan university mountain country collection of typical cultures, post code: 430072, the preservation number is CCTCC NO: M20231646, and the preservation date is 2023, 9 and 7. The strain was used as a production strain in the following.
The specific application method comprises inoculating Serratia marcescens LT-7 in a solid culture medium, transferring to a seed culture medium, inoculating to a fermentation culture medium, performing aerobic culture, and adding (+ -) -MPGM and toluene into the fermentation broth to obtain prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM.
The Serratia marcescens LT-7 and the application of the Serratia marcescens LT-7 in preparing prodigiosin and (2R, 3S) - (-) -MPGM sequentially comprise the following steps:
1. Preparing a culture medium:
(1) Slant culture medium components: 10g/L of tryptone, 10g/L of NaCl, 5g/L of yeast powder, 20g/L of agar and the balance of water, wherein the pH value is 6.0-7.0, preferably 6.8;
(2) Solid seed medium: 10g/L of tryptone, 10g/L of NaCl, 5g/L of yeast powder, 20g/L of agar, pH value of 6.8, the balance of water, and pH value of 6.0-7.0, preferably 6.8;
(3) Liquid seed medium: 15g/L of tryptone, 10g/L of maltose, pH value of 6.8 and the balance of water, wherein the pH value is 6.4-8.0, preferably 6.8;
(4) Fermentation medium: 5-15 g/L of carbon source, 10-20 g/L of nitrogen source, 0.005-1 g/L of metal salt, 6.4-8.0 of pH value, 2-5 g/L of proline and water as solvent.
Wherein the carbon source is any one or the combination of more than one of sugarcane juice, molasses, sucrose, mannose and glycerol; molasses is preferred, and the addition amount of the molasses is preferably 10g/L;
The nitrogen source is any one or a combination of a plurality of tryptone, soybean peptone, peanut cake powder and soybean cake powder, preferably tryptone, and the addition amount of the tryptone is preferably 15g/L;
The metal salt is magnesium sulfate, and most preferably 0.8g/L of magnesium sulfate;
The most preferred fermentation medium is as follows: 10g/L molasses, 15g/L tryptone, 0.8g/L magnesium sulfate, 25g/L tween-80 and 3g/L proline, and the solvent is water.
2. And (3) strain selection:
the deposited strain Serratia marcescens LT-7 was selected.
3. Activating strains:
Inoculating Serratia marcescens LT-7 strain into slant culture medium, standing at 20-30 deg.c for 18-34 hr, and then picking single colony into common solid culture medium for three-area line and standing at 20-30 deg.c for 18-34 hr to obtain activated strain.
4. Seed liquid preparation:
And (3) inoculating the activated strain obtained in the step (3) into a shaking bottle of the seed liquid under the aseptic condition, and culturing the seed liquid in a shaking table with the temperature of 30 ℃ and the rotating speed of 200rpm for 12 hours in a dark place to obtain the seed liquid.
5. Shake flask fermentation culture:
Inoculating the seed solution obtained in the step 4 into a fermentation culture shake flask with an inoculum size of 3% under aseptic condition, and culturing in dark for 36h at a temperature of 32deg.C and a rotation speed of 250 rpm. Fermentation is stopped when the concentration of prodigiosin and (2R, 3S) - (-) -MPGM in the fermentation broth is substantially no longer rising.
6. Fermentation and culture in a fermentation tank:
Inoculating the seed liquid obtained in the step 4 into a 50L fermentation tank with an inoculum size of 3% under aseptic condition, wherein the total liquid loading amount of the fermentation liquid is 35L, the fermentation temperature is 32 ℃, the stirring speed is 250rpm, the pH is 6.8, the ventilation amount is 0.9-1.1 VVM, and the fermentation time is 46h; fermentation is stopped when the concentration of prodigiosin and (2R, 3S) - (-) -MPGM in the fermentation broth is substantially no longer rising.
7. Preparation of (2R, 3S) - (-) -MPGM:
When fermentation is carried out for 38 hours, 5-20 g/L (+ -) -MPGM and 0.5-1 times volume of toluene of the fermentation broth are added into the culture broth, and the culture is stopped after continuous culture for 2-8 hours at the temperature of 32 ℃ and the rpm of 250 on a shaking table.
8. Extraction of prodigiosin and (2R, 3S) - (-) -MPGM:
(1) Preparing a crude product: centrifuging Serratia marcescens LT-7 fermentation liquor, extracting thallus with 2 times methanol until thallus becomes white, mixing with supernatant, concentrating 3-5 times, adding equal volume of ethyl acetate for overnight extraction, filtering organic phase, and rotary evaporating to concentrate into extract-like coarse body.
(2) Extraction of prodigiosin and (2R, 3S) - (-) -MPGM: the organic phase of (1) was washed with 5% NaHSO 3 and then with 5% NaHCO 3, and dried over magnesium sulfate to give (2R, 3S) - (-) -MPGM. 200-300 mesh silica gel is used as a stationary phase, and petroleum ether: ethyl acetate=7: 3 as mobile phase, dissolving the residual organic phase with methanol, loading, purifying the prodigiosin by adopting a silica gel column chromatography method, collecting the component with the corresponding Rf value, rotationally evaporating, concentrating, and freeze-drying for 24 hours to obtain the prodigiosin.
9. Prodigiosin content determination:
The prodigiosin standard with a constant dry weight was precisely weighed and prepared as standard solutions of 0.05, 0.10, 0.15, 0.20, 0.25 and 0.30mg/mL, and absorbance was measured at 535 nm. And drawing a standard curve by taking absorbance as an ordinate and concentration as an abscissa to obtain a regression equation, and calculating the content of the prodigiosin according to the standard curve as shown in the figure.
10. Identification of prodigiosin
And (3) identifying Serratia marcescens LT-7 fermentation products by adopting a high performance liquid chromatograph, an infrared spectrometer and a nuclear magnetic resonance spectrometer.
10Mg of prodigiosin purified product is dissolved in 100ml of methanol, and the pH is adjusted to 3, so that prodigiosin methanol solution is obtained, and the liquid chromatography result is shown in figure 1.
And (3) identifying an infrared spectrum of the purified product of the serratia marcescens LT-7 fermented prodigiosin by using an infrared spectrometer, grinding and tabletting 0.2mg of a sample and a small amount of KBr to prepare the sample, and measuring the infrared spectrum of the sample by using the infrared spectrometer, wherein the scanning range is 4000-400 cm -1 (figure 2). NMR 1 H and NMR 13 C were performed on Serratia marcescens LT-7 fermentation purified product using CD 3 Cl as solvent. The results are shown in fig. 3 and 4.
The beneficial effects are that:
According to the invention, the serratia marcescens S.marcescens LT-7 capable of co-producing prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM is obtained through first screening, the highest concentration of prodigiosin in a fermentation medium is 27.6g/L, the highest concentration of diltiazem intermediate (2R, 3S) - (-) -MPGM is 17.3g/L, the highest conversion rate can reach 86.5%, the production period is greatly shortened, the process is simple, and the cost is reduced, so that the serratia marcescens S.marcescens has important social and economic significance for producing prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM.
Drawings
FIG. 1 is a phylogenetic tree of Serratia marcescens LT-7.
FIG. 2 is a high performance liquid chromatogram of Serratia marcescens LT-7 prodigiosin.
FIG. 3 is a Fourier infrared spectrum of Serratia marcescens LT-7 prodigiosin.
FIG. 4 is a NMR 1 H analysis of Serratia marcescens LT-7 prodigiosin.
FIG. 5 is a NMR 13 C analysis chart of Serratia marcescens LT-7 prodigiosin.
FIG. 6 is an effect of carbon source species on co-production of prodigiosin and diltiazem intermediates.
FIG. 7 is an effect of carbon source concentration on co-production of prodigiosin and diltiazem intermediates.
FIG. 8 is an effect of nitrogen source species on co-production of prodigiosin and diltiazem intermediates.
FIG. 9 is an effect of nitrogen source concentration on co-production of prodigiosin and diltiazem intermediates.
Figure 10 is an effect of metal salt species and their concentration on co-production of prodigiosin and diltiazem intermediates.
FIG. 11 is the effect of Tween-80 concentration on co-production of prodigiosin and diltiazem intermediates.
FIG. 12 is an effect of temperature on co-production of prodigiosin and diltiazem intermediates.
FIG. 13 is an effect of pH on co-production of prodigiosin and diltiazem intermediates.
Figure 14 is the effect of inoculum size on co-production of prodigiosin and diltiazem intermediate.
FIG. 15 is an effect of an intermediate preparation process on co-production of prodigiosin and diltiazem intermediates.
The intermediate preparation conditions of figure 16 are the effect on co-production of prodigiosin and diltiazem intermediates.
FIG. 17 is a plot of the progress of 50L fermentor fed-batch co-production of prodigiosin and diltiazem intermediates.
FIG. 18 is a graph of the progress of fed-batch co-production of prodigiosin and diltiazem intermediates in a 1t fermenter.
The specific embodiment is as follows:
The invention may be better understood from the following examples, which are set forth to illustrate, but are not to be construed to limit the invention to the details of the claims, as will be apparent to those skilled in the art.
Example 1: isolation and screening of Serratia marcescens LT-7
The composition of the medium used in this example is as follows:
LB solid medium: 10g/L of peptone, 10g/L of sodium chloride, 5g/L of yeast powder, 20g/L of agar and the balance of water, and sterilizing for 20min at 121 ℃.
The specific operation procedure of this example is as follows:
The procedure for screening pigment-producing bacteria was as follows: microbial pigment-producing bacteria were selected from 60 parts of soil from various places throughout the country, 1g each was added to a triangular flask containing sterile enrichment medium, and the mixture was subjected to enrichment culture at 30℃on a shaker at 200rpm for 48 hours. 1mL of the culture solution is transferred to the same liquid enrichment culture medium for culturing for 48 hours under the same conditions. Under the aseptic condition, diluting the culture solution to 10 -6 and 10 -7, respectively taking 0.2mL of the culture solution to be coated in LB solid culture medium, culturing for 48 hours at 30 ℃, screening positive strains according to the surface color of bacterial colonies, separating and purifying, inoculating the positive strains into a fermentation culture medium, culturing for 48 hours at 30 ℃ and 200rpm, and measuring the yield of pigment of the primary screened strain to obtain the strain with the highest yield. In subsequent experiments with various physiological and biochemical assays, it was found that a certain amount of lipase was contained therein. The lipase can split (+ -) -MPGM to obtain the diltiazem key intermediate (2R, 3S) - (-) -MPGM.
Example 2: identification of Serratia marcescens LT-7.
Extracting genome DNA of Serratia marcens LT-7 by using a bacterial genome DNA extraction kit, amplifying a 16S rDNA sequence by using an upstream primer 27F and a downstream primer 1492R PCR, carrying out gel recovery and purification on the PCR amplified product, and sending the gel recovery and purification product to Suzhou gold and other intelligent biotechnology Co. The length of the nucleotide sequence of the 16S rDNA gene of the strain is 1471bp, and the gene sequence is shown as SEQ ID No.1: as shown. The sequences were compared for homology from the Gene Bank database using the BLAST program, and a 16SrDNA full sequence-based phylogenetic tree was constructed (FIG. 1). The results show that: the strain has 100% homology with Serratia marcescens JW-CZ 2. According to the morphological observation of the strain and the analysis result of physiological and biochemical experiments, serratia marcescens, specifically Serratia marcescens LT-7, is adopted.
Example 3: identification of the fermentation product prodigiosin of Serratia marcescens LT-7
Seed liquid culture mediums of Serratia marcescens LT-7 are respectively inoculated into the same fermentation culture mediums (the composition of the fermentation culture mediums is as follows, molasses is 10g/L, tryptone is 15g/L, magnesium sulfate is 0.8g/L, tween-80 is 25g/L and proline is 3 g/L) according to the inoculation amount of 3.5 percent, the pH value is adjusted to 6.8, the culture is carried out at 32 ℃ under the shaking condition of 250rpm, the liquid content of the fermentation culture mediums is 50mL/250mL conical flask, and the fermentation culture is stopped after 38 hours.
Centrifuging the LT-7 pigment fermentation liquor at 9000rpm, adding 1-2 times of methanol into the sediment for leaching, concentrating the supernatant into 1/5 of the original volume by rotary evaporation at 55-65 ℃, adding 3-5 times of methanol, standing overnight in a refrigerator at 4 ℃, combining with the settled methanol solution, centrifuging, filtering, adding 1-2 times of water for extraction, and concentrating the organic phase to obtain a prodigiosin crude product; the crude product is dissolved in 2 times of methanol for standby. The prodigiosin is separated and purified by adopting a silica gel chromatographic column, and petroleum ether is adopted as a mobile phase: acetone (7:3), silica gel with 200-300 meshes, and concentrating the purified solution by rotary evaporation at 50 ℃ and freeze-drying to obtain prodigiosin powder.
10Mg of prodigiosin purified product was dissolved in 10mL of acidic methanol to obtain prodigiosin methanol solution, and the liquid chromatography result thereof was shown in FIG. 2.
And (3) identifying an infrared spectrum of the purified product of the serratia marcescens LT-7 fermented prodigiosin by using an infrared spectrometer, grinding and tabletting 0.2mg of a sample and a small amount of KBr, and measuring the infrared spectrum of the sample by using the infrared spectrometer, wherein the scanning range is 4000-400 cm -1 (figure 3). The purified product of Serratia marcescens LT-7 fermentation was subjected to (NMR) 1 H and (NMR) 13 H detection using CD 3 Cl as a solvent. The results are shown in fig. 4 and 5.
Example 4: optimization of the carbon source types of the combined production of prodigiosin and diltiazem intermediates by Serratia marcescens.
This example illustrates the effect of different carbon source species on the yield of prodigiosin and diltiazem intermediates prepared by fermentation of the strain.
Seed liquid culture medium is respectively inoculated into fermentation culture medium containing 15g/L (total sugar concentration in fermentation liquid) of Sugarcane Juice (SJ), molasses (CM), sucrose (Suc), mannose (Mal) and glycerin (Gly) in an inoculum size of 3% (v/v) (other components of the fermentation culture medium are as follows: tryptone 15g/L, magnesium sulfate 0.8g/L, tween-80 25g/L and proline 3 g/L), initial pH value is 7.0, shaking culture is carried out at 28 ℃ and 250rpm, liquid loading amount of the fermentation culture medium is 50mL/250mL conical flask, diltiazem intermediate (2R, 3S) - (-) -MPGM is prepared after fermentation culture is carried out for 38 hours, and 15g/L of (+ -) -MPGM and 25mL toluene are respectively added to carry out continuous reaction on a shaking table for 2 hours. And (3) taking fermentation solutions of different carbon sources for content measurement, and calculating the yield of the prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM. The highest yield was found when the carbon source was chosen as molasses. Prodigiosin yields were about 7.1g/L, production rates as high as 0.19g/L/h, and diltiazem intermediates yields were about 5.42g/L (FIG. 6).
Example 5: and (3) optimizing the carbon source concentration of the combined prodigiosin and diltiazem intermediate of Serratia marcescens.
This example illustrates the effect of different carbon source concentrations on the yields of prodigiosin and diltiazem intermediates prepared by fermentation of the strains, seed solution medium was inoculated in an inoculum size of 3% (v/v) into fermentation medium containing 0g/L, 5g/L, 10g/L, 15g/L, 20g/L molasses (other components of the fermentation medium are as follows: tryptone 15g/L, magnesium sulfate 0.8g/L, tween-80 25g/L, proline 3 g/L), initial pH value was 7.0, shaking culture was carried out at 28℃at 250rpm, the medium volume was 50mL/250mL Erlenmeyer flask, diltiazem intermediate (2R, 3S) - (-) -MPGM) was prepared after fermentation culture for 38 hours, 15g/L (. + -.) -MPGM and 25mL toluene were added respectively, and the reaction was continued on a shaker for 2 hours. Measuring the content of fermentation liquid with different carbon sources, and calculating the yield of prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM. The highest yield was found when the carbon source concentration was selected to be 10 g/L. Prodigiosin yields were about 8.1g/L, production rates as high as 0.21g/L/h, and diltiazem intermediates yields were about 7.77g/L (FIG. 7).
Example 6: optimization of the nitrogen source species of Serratia marcescens co-produced prodigiosin and diltiazem intermediates.
This example illustrates the effect of different nitrogen sources on the yields of prodigiosin and diltiazem intermediates prepared by fermentation of the strains, seed solution medium was inoculated in an inoculum size of 3% (v/v) into a fermentation medium containing 10g/L tryptone (A), soybean peptone (B), peanut cake (C) and soybean cake (D) (other components of the fermentation medium are as follows: molasses 10g/L, magnesium sulfate 0.8g/L, tween-80 25g/L, proline 3 g/L), initial pH was 7.0, shaking culture was carried out at 28℃and 250rpm, the medium volume was a 50mL/250mL Erlenmeyer flask, and after fermentation culture for 38 hours, diltiazem intermediate (2R, 3S) - (-) -MPGM was prepared by adding 15g/L of (+ -) -MPGM and 25mL toluene, respectively, and continuing the reaction on a shaker for 2 hours. And (3) taking fermentation solutions of different nitrogen sources for content measurement, and calculating the yield of the prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM. The highest yield was found when the nitrogen source was selected as tryptone. Prodigiosin yields were about 12.6g/L, production rates as high as 0.33g/L/h, and diltiazem intermediates yields were about 7.92g/L (FIG. 8).
Example 7: and (3) optimizing nitrogen source concentration of the combined prodigiosin and diltiazem intermediate of Serratia marcescens.
This example illustrates the effect of different nitrogen source concentrations on the yields of prodigiosin and diltiazem intermediates prepared by fermentation of the strain, seed solution medium was inoculated in an inoculum size of 3% (v/v) into a fermentation medium containing 5g/L, 10g/L, 15g/L and 20g/L tryptone (other components of the fermentation medium are as follows: molasses 10g/L, magnesium sulfate 0.8g/L, tween-80 25g/L and proline 3 g/L), initial pH was 7.0, shaking culture was carried out at 28℃at 250rpm, the liquid loading of the fermentation medium was a 50mL/250mL Erlenmeyer flask, diltiazem intermediate (2R, 3S) - (-) -MPGM was prepared after fermentation culture for 38 hours, and 15g/L of (+ -) -MPGM and 25mL toluene were added, respectively, and the reaction was continued on a shaker for 2 hours. Measuring the content of fermentation liquid with different nitrogen sources, and calculating the yield of prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM. The highest yield was found when the nitrogen source concentration was selected to be 15 g/L. Prodigiosin yields were about 13.3g/L, production rates as high as 0.35g/L/h, and diltiazem intermediates yields were about 8.4g/L (FIG. 9).
Example 8: and (3) optimizing the concentration of metal salts required by the Serratia marcescens for co-producing prodigiosin and diltiazem intermediate.
This example illustrates the effect of different metal salts and their concentrations on the yield of prodigiosin and diltiazem intermediates prepared by fermentation of strains, seed culture broth was inoculated in an inoculum size of 3% (v/v) into a medium containing the following magnesium sulfate concentrations (other components of the medium are as follows: 10g/L molasses, 15g/L tryptone, 25g/L tween-80, 3g/L proline) respectively, as follows: magnesium sulfate: 0.2, 0.4, 0.6, 0.8, 1.0 and 1.2g/L and control, the optimal concentration of magnesium sulfate is 0.8g/L; for the fermentation culture medium of the experimental group, 3 groups of parallel controls are arranged, the initial pH value is 7.0, the culture medium is subjected to shaking culture at 28 ℃ and 250rpm, the liquid loading amount of the culture medium is a 50mL/250mL conical flask, 15g/L (+ -) -MPGM and 25mL toluene are respectively added into the fermentation culture medium for fermentation culture for 38 hours, the reaction is continued for 2 hours on a shaking table, the fermentation liquid under each metal salt concentration is taken for content measurement, and the yield of prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM) is calculated. When the metal salt was selected to have a magnesium sulfate concentration of 0.8g/L, the prodigiosin yield was about 14.7g/L, the production rate was as high as 0.39g/L/h, and the diltiazem intermediate yield was about 7.8g/L (FIG. 10).
Example 9: and (3) optimizing the concentration of the combined prodigiosin and diltiazem intermediate Tween-80 by Serratia marcescens.
This example illustrates the effect of different concentrations of Tween-80 on the production of prodigiosin and diltiazem intermediate by fermentation of the strain, seed solution medium was inoculated in an inoculum size of 3% (v/v) into 15g/L, 20g/L, 25g/L, 30g/L, 35g/L Tween-80 fermentation medium (other ingredients of the fermentation medium were as follows: molasses 10g/L, tryptone 15g/L, magnesium sulfate 0.8g/L, proline 3 g/L), initial pH was 7.0, shaking culture was carried out at 28℃at 250rpm, the medium volume was a 50mL/250mL Erlenmeyer flask, and diltiazem intermediate (2R, 3S) - (-) -MPGM) was prepared after 38h fermentation culture, and reaction was continued on a shaker with 15g/L (+ -) -MPGM and 25mL toluene, respectively, for 2h. The fermentation broths of Tween-80 with different concentrations are used for content measurement, and the yields of prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM are calculated. The highest yield was found when Tween-80 was selected at a concentration of 25 g/L. Prodigiosin yields were about 16.9g/L, production rates as high as 0.44g/L/h, and diltiazem intermediates yields were about 8.3g/L (FIG. 11).
Example 10: optimization of temperature of Serratia marcescens co-produced prodigiosin and diltiazem intermediate.
This example illustrates the effect of culturing at different temperatures on the yields of prodigiosin and diltiazem intermediates prepared by fermentation of the strain, seed liquid medium was inoculated in an inoculum size of 3% (v/v) into the same fermentation medium (composition of fermentation medium is as follows: molasses 10g/L, tryptone 15g/L, magnesium sulfate 0.8g/L, tween-80 25g/L, proline 3 g/L), initial pH was 7.0, shaking culture was carried out at 26 ℃, 28 ℃, 30 ℃, 32 ℃, 34 ℃,250rpm, the volume of the fermentation medium was 50mL/250mL Erlenmeyer flask, diltiazem intermediate (2R, 3S) - (-) -MPGM was prepared after fermentation culture for 38 hours, and 15g/L of (+ -) -MPGM and 25mL toluene were added, respectively, and the reaction was continued on a shaker for 2 hours. The fermentation broths cultured at different temperatures are taken for content measurement, and the yields of prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM are calculated. The highest yield was found at a selection temperature of 32 ℃. Prodigiosin yields were about 18.2g/L, production rates as high as 0.48g/L/h, and diltiazem intermediates yields were about 9.6g/L (FIG. 12).
Example 11: and (3) optimizing the pH value of the combined prodigiosin and diltiazem intermediate of Serratia marcescens.
This example illustrates the effect of culturing in different pH values on the yields of prodigiosin and diltiazem intermediates prepared by fermentation of the strain, seed liquid medium was inoculated in the same fermentation medium in an inoculum size of 3% (v/v) respectively (composition of fermentation medium is as follows: molasses 10g/L, tryptone 15g/L, magnesium sulfate 0.8g/L, tween-80 g/L, proline 3 g/L), pH values were adjusted to 6.4, 6.8, 7.2, 7.6, 8.0 at 32 ℃, shaking culture was carried out at 250rpm, the liquid loading amount of fermentation medium was 50mL/250mL Erzem flask, diltiazem intermediate (2R, 3S) - (-) -MPGM was prepared after fermentation culture for 38 hours, and 15g/L of (+ -) -MPGM and 25mL toluene were added respectively, and the reaction was continued on a shaking table for 2h. Measuring the content of fermentation liquids with different pH values, and calculating the yield of the prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM. The highest yield was found when the pH was chosen at 6.8. Prodigiosin yields were about 19.4g/L, production rates as high as 0.51g/L/h, and diltiazem intermediates yields were about 10.5g/L (FIG. 13).
Example 12: optimization of the inoculum size of the combined production of prodigiosin and diltiazem intermediate by Serratia marcescens.
This example illustrates the effect of different inoculum size on the yield of prodigiosin and diltiazem intermediates prepared by fermentation of the strain, seed solution medium was inoculated in the same fermentation medium in an inoculum size of 2%, 2.5%, 3%, 3.5%, 4% (v/v) (composition of fermentation medium is as follows: molasses 10g/L, tryptone 15g/L, magnesium sulfate 0.8g/L, tween-80 g/L, proline 3 g/L), pH was adjusted to 6.8 at 32 ℃, shaking culture was carried out at 250rpm, fermentation medium was filled in a 50mL/250mL Erlenmeyer flask, diltiazem intermediate (2R, 3S) - (-) -MPGM was prepared after 38h fermentation culture, and reaction was continued on shaking table-type MPGM and 25mL toluene for 2h, respectively. The different precursor fermentation broths are taken for content measurement, and the yields of prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM are calculated. The highest yield was found when the inoculum size was 3.5%. Prodigiosin yields were about 21.5g/L, production rates as high as 0.57g/L/h, and diltiazem intermediates yields were about 10.1g/L (FIG. 14).
Example 13: the preparation method of the diltiazem intermediate produced by Serratia marcescens fermentation is optimized.
This example illustrates the effect of substrate concentration addition on conversion of a fermentatively produced diltiazem intermediate. Inoculating the seed solution culture medium into the same fermentation culture medium (the composition of the fermentation culture medium is as follows: molasses 10g/L, tryptone 15g/L, magnesium sulfate 0.8g/L, tween-80 25g/L and proline 3 g/L) respectively, adjusting the pH value to 6.8, carrying out shaking culture at 32 ℃ and 250rpm, wherein the liquid loading amount of the fermentation culture medium is 50mL/250mL conical flask, preparing diltiazem intermediate (2R, 3S) - (-) -MPGM after 38h of fermentation culture, and respectively adding 0, 5, 10, 15, 20, 25 and 30g/L (+ -) -MPGM and 25mL toluene to continuously react on a shaking table for 2h. And (3) taking different fermentation broths for content measurement, and calculating the yield of the prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM. The highest yield was found at a (+ -) -MPGM concentration of 20 g/L. Prodigiosin yield was about 23.1g/L, production rates were as high as 0.61g/L/h, diltiazem intermediate yield was about 14.9g/L, and conversion was 73.0% (FIG. 15).
Example 14: the preparation condition of the diltiazem intermediate produced by Serratia marcescens fermentation is optimized.
This example illustrates the effect of a toluene-water system on the conversion of a fermentatively produced diltiazem intermediate. Inoculating the seed solution culture medium into the same fermentation culture medium (the composition of the fermentation culture medium is as follows: molasses 10g/L, tryptone 15g/L, magnesium sulfate 0.8g/L, tween-80 25g/L and proline 3 g/L) respectively, adjusting the pH value to 6.8, carrying out shaking culture at 32 ℃ and 250rpm, wherein the liquid loading amount of the fermentation culture medium is 50mL/250mL conical flask, preparing diltiazem intermediate (2R, 3S) - (-) -MPGM after 38h fermentation culture, and respectively adding 20g/L of (+ -) -MPGM and 10, 15, 20, 25 and 30mL of toluene to continuously react on a shaking table for 2h. And (3) taking different fermentation broths for content measurement, and calculating the yield of the prodigiosin and diltiazem intermediate (2R, 3S) - (-) -MPGM. The yield was found to be highest when 25mL toluene was added. Prodigiosin yield was about 23.7g/L, production rates were as high as 0.62g/L/h, diltiazem intermediate yield was about 16.3g/L, and conversion was 81.5% (FIG. 16).
Example 15: the 50L fermentor is fed in batches to co-produce prodigiosin and diltiazem intermediates.
Inoculating Serratia marcescens LT-7 strain into a solid culture medium, standing at 28 ℃ for 24 hours, picking single bacterial colony again for full-drawing on the solid culture medium, standing at 28 ℃ for 24 hours, taking the full-drawing strain, hanging 1 ring in a shake flask containing a seed liquid culture medium under aseptic condition, and culturing for 24 hours on a shake flask with the rotating speed of 200rpm and the temperature of 30 ℃ to obtain fermentation seed liquid; inoculating the seed solution into a fermentation medium with an inoculum size of 5%, and regulating the pH value to 6.8 by using dilute hydrochloric acid; the total liquid loading amount of the fermentation tank is 35L, the fermentation temperature is 32 ℃, the stirring speed is 250rpm, and the ventilation amount is 1.0VVM for fermentation; the fermentation pH value is constant at 6.8, an automatic pH control device is started in the fermentation process, and the pH is controlled by dilute hydrochloric acid; 10g/L of molasses is supplemented when fermentation is carried out for 30 hours, and the total fermentation time is 38 hours. After completion of fermentation, (2R, 3S) - (-) -MPGM was prepared by sampling and measuring the yield of prodigiosin in the fermentation broth every 2 hours. Assay analysis: taking the fermentation liquor, centrifuging at 10000rpm for 3min, taking supernatant to dilute 500 times, and detecting that the prodigiosin yield in the fermentation liquor after one feeding is about 25.4g/L, the production rate is as high as 0.67g/L/h, the yield of diltiazem intermediate is about 16.9g/L, and the conversion rate is 84.5% (shown in figure 17).
Example 16: batch feeding of 1t tank to co-produce prodigiosin and diltiazem intermediate
Inoculating Serratia marcescens LT-7 strain into a solid culture medium, standing at 28 ℃ for 24 hours, picking single bacterial colony again for full-drawing on the solid culture medium, standing at 28 ℃ for 24 hours, taking the full-drawing strain, hanging 1 ring in a shake flask containing a seed liquid culture medium under aseptic condition, and culturing for 24 hours on a shake flask with the rotating speed of 200rpm and the temperature of 30 ℃ to obtain fermentation seed liquid; inoculating the seed solution into a fermentation medium with an inoculum size of 5%, and regulating the pH value to 6.8 by using dilute hydrochloric acid; the total liquid loading amount of the fermentation tank is 700L, the fermentation temperature is 32 ℃, the stirring rotation speed is 250rpm, and the ventilation amount is 1.0VVM for fermentation; the fermentation pH value is constant at 6.8, an automatic pH control device is started in the fermentation process, and the pH is controlled by dilute hydrochloric acid; 10g/L of molasses is supplemented when fermentation is carried out for 30 hours, and the total fermentation time is 38 hours. The yield of prodigiosin in the fermentation broth was determined by sampling every 2h and (2R, 3S) - (-) -MPGM was prepared after the fermentation was completed. Assay analysis: taking the fermentation liquor, centrifuging at 10000rpm for 3min, taking supernatant to dilute 500 times, and detecting that the prodigiosin yield in the fermentation liquor after one feeding is about 27.6g/L, the production rate is as high as 0.73g/L/h, the yield of diltiazem intermediate is about 17.3g/L, and the conversion rate is 86.5% (shown in figure 18).
Finally, it should also be noted that the above list is only a specific embodiment of the present invention. Obviously, the invention is not limited to the above embodiments, but many variations are possible. All modifications which can be directly derived or suggested by the person skilled in the art from the present disclosure should be considered as the protection scope of the present invention.
Claims (10)
1. The application of Serratia marcescens in the co-production of prodigiosin and diltiazem intermediate is characterized in that the Serratia marcescens is classified as Serratia marcescens SERRATIA MARCESCENS LT-7, and is preserved in China Center for Type Culture Collection (CCTCC) with the preservation number of M20231646 and the preservation date of 2023, 9 and 7 days.
2. The use according to claim 1, wherein serratia marcescens LT-7 is inoculated into a fermentation medium for aerobic fermentation, and (±) -MPGM and toluene are added into the fermentation broth to prepare prodigiosin and diltiazem intermediate (2 r,3 s) - (-) -MPGM.
3. The use according to claim 2, wherein the fermentation medium comprises the following components:
1-20 g/L of molasses, 5-20 g/L of tryptone, 0.2-1.2 g/L of magnesium sulfate, 15-35 g/L of tween-80 and 2-5 g/L of proline, and adjusting the initial pH value of fermentation liquor to 6.0-7.0 by using water as a solvent.
4. Use according to claim 3, characterized in that the initial pH of the fermentation broth is adjusted to 6.0-7.0 with sodium bicarbonate.
5. The use according to claim 2, wherein the aerobic fermentation is carried out under the following conditions: the temperature is 26-34 ℃, the speed is 220-250 rpm, and the culture time is 24-38 h.
6. The use according to claim 5, wherein when the aerobic fermentation is shake flask culture, the seed liquid is inoculated in an amount of 2 to 4% by volume of the fermentation liquid, and the culture time is 24 to 38 hours.
7. The use according to claim 5, wherein when the aerobic culture is a fermenter culture, the seed liquid is inoculated in an amount of 3 to 6% by volume of the fermentation liquid, and the aeration rate is 1.0 to 1.4VVM.
8. The use according to claim 2, wherein the aerobic fermentation is fed-batch fermentation.
9. The use according to claim 8, wherein the fed-batch fermentation is a fermentation to 30 hours with the addition of molasses at 5-10 g/L.
10. The use according to claim 2, characterized in that (±) -MPGM in an amount of 5-20 g/L and toluene in an amount of 0.5-1 times the total volume of the fermentation broth are added to the fermentation broth when the yield of prodigiosin in the fermentation broth is no longer increased, and then the culture is continued at 32 ℃ for 2-3 hours under 250rpm to prepare diltiazem intermediate (2 r,3 s) - (-) -MPGM.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311835867.4A CN117925747A (en) | 2023-12-28 | 2023-12-28 | Application of Serratia marcescens in co-production of prodigiosin and diltiazem intermediate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311835867.4A CN117925747A (en) | 2023-12-28 | 2023-12-28 | Application of Serratia marcescens in co-production of prodigiosin and diltiazem intermediate |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117925747A true CN117925747A (en) | 2024-04-26 |
Family
ID=90769541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311835867.4A Pending CN117925747A (en) | 2023-12-28 | 2023-12-28 | Application of Serratia marcescens in co-production of prodigiosin and diltiazem intermediate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117925747A (en) |
-
2023
- 2023-12-28 CN CN202311835867.4A patent/CN117925747A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2016179735A1 (en) | A method of semi-solid state fermentation for producing surfactin from a mutant strain of bacillus subtilis subsp | |
Awad et al. | Efficient production process for food grade acetic acid by Acetobacter aceti in shake flask and in bioreactor cultures | |
CN1076965A (en) | New fungal bacterial strain and the application in production of antibiotics thereof | |
US9689017B2 (en) | Method of semi-solid state fermentation for producing surfactin from a mutant strain of Bacillus subtilis subsp | |
CN113481106A (en) | Deep sea source penicillium mycoides and obtained compound | |
CN111518710B (en) | Enterobacter strain and application thereof in preparation of microbial polysaccharide | |
CN111518711B (en) | Enterobacter strain and application thereof in coproduction of microbial exopolysaccharide and 2,3-butanediol | |
CN112143664A (en) | Bacillus belgii strain and application thereof in synthesis of microbial polysaccharide | |
CN117106595A (en) | Industrial cannabis endophytic fungus HMY07 capable of producing flavonoid compounds and application thereof | |
CN117925747A (en) | Application of Serratia marcescens in co-production of prodigiosin and diltiazem intermediate | |
CN113337432B (en) | Methylophilus for producing pyrroloquinoline quinone and application thereof | |
CN110551638B (en) | Penicillium citrinum and application thereof in production of citrinin | |
CN112176012B (en) | Bacillus belgii and application thereof in coproduction of microbial polysaccharide and gamma-polyglutamic acid | |
CN111518712B (en) | Enterobacter strain and application thereof in synthesis of 2,3-butanediol | |
CN112143681B (en) | Bacillus belgii capable of producing feruloyl esterase and application thereof | |
CN110358687B (en) | Gibberellin for producing D-pantolactone hydrolase and application and fermentation method thereof | |
CN115044483B (en) | Penicillium fungus W21C371 and application thereof in preparation of curvulin | |
CN108277170B (en) | New mycobacterium aureofaciens and application thereof in preparation of 9-hydroxyprogesterone | |
CN109971652B (en) | Tibetan pineapple endophytic fungus oncogenes X117 and preparation method and application of fermentation product thereof | |
CN114196552B (en) | Aspergillus terreus BTBU20212047 and application thereof | |
CN114933976B (en) | Monilinia mountain Monilis and application thereof | |
CN113980821B (en) | Aspergillus niger capable of converting hesperidin and application thereof | |
CN107354182A (en) | A kind of method that grey green soy bean endogenetic fungus fermentation prepares the oxazolidinone compounds of (R) 4 benzyl 2 | |
CN108485991B (en) | Saccharopolyspora marinum and application thereof in preparation of erythromycin derivative | |
CN118599948A (en) | Method for co-producing prodigiosin and beta-carotene by mixed fermentation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |